Tech companies are revamping computing — from how tiny chips are built to the way they are arranged, cooled and powered — in the race to build artificial intelligence that recreates the human brain.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each ...